Re: The Prescription....Nove... 15th
in response to
by
posted on
Nov 17, 2017 11:58AM
Page 1 of the Beacon report states :
Shares Outstanding:
Basic 174.6 (X Closing Price 1.29) = Market Cap $225.3(cad)
Fully Diluted 198.6 (X Closing Price 1.29) = Market Cap $256.2
Implied:
Basic 174.6 (X 12 Month Price Target 8.55) = Risk Adjusted NPV CVD & CKD =1,493(Cad)
Fully Dil 198.6 ......................................................................................... 1,700
The Beacon projection IMO is in error since it states two different market values based on shares outstanding and fully diluted shares outstanding. The fully diluted price per share should be modified to adjust for the additional shares issued. The fully diluted value per share should be (C$)7.52 (1,493 / 198.6)
The Beacon Report is misleading - is $ 8.55 Basic or fully diluted? How can you have two different market caps for the same company based on shares O/S and fully diluted shares O/S- the variable should be the price per share - I believe that's what is confusing everyone.
It's all smoke and mirrors anyway.
Chicagoest